Scadenza: 4 June 2020
Topic:
Integrative approaches in human biology and related toxicity pathways to propose and demonstrate scientifically valid means for comprehensive safety assessment of chemicals without resorting to animal testing
Programma:
Horizon 2020 SC1 "Health, demographic change and wellbeing"
Priority 1.2: Innovative health and care industry
Budget complessivo:
EUR 60 million
Status:
Closed
Quota finanziabile:
between EUR 10 and 20 million
Topic:
Integrative approaches in human biology and related toxicity pathways to propose and demonstrate scientifically valid means for comprehensive safety assessment of chemicals without resorting to animal testing
Who can participate:
Programme:
Horizon 2020 SC1 "Health, demographic change and wellbeing"
Priority 1.2: Innovative health and care industry
Consortium:
Status: Open
Total budget:
EUR 60 million
Funding rate:
between EUR 10 and 20 million
Notes:
Scope:
- Integrative approaches in human biology and related toxicity pathways to propose and demonstrate scientifically valid means for comprehensive safety assessment of chemicals without resorting to animal testing
- Establish the scientific credibility of the approaches for a variety of relevant decision-making contexts and regulatory requirements
- Cooperation with complementary initiatives in and outside the EU, including with industry, and Joint research Center (JRC)
Impact:
- Scientifically sound, practicably implementable non-animal solutions deployable to inform safety assessment of chemicals across sectors
- Recognition from regulatory bodies and their engagement to translate results, methods and solutions into safety assessment practice
- Reduced use of laboratory animals in safety testing
